OpenURL Connection Search

Select item for more details and to access through your institution.

Schistocytes in disseminated intravascular coagulation.
Published in:
International Journal of Laboratory Hematology, 2014, v. 36, n. 4, p. 439, doi. 10.1111/ijlh.12168
By:
- Lesesve, J.‐F.;
- Martin, M.;
- Banasiak, C.;
- André‐Kerneïs, E.;
- Bardet, V.;
- Lusina, D.;
- Kharbach, A.;
- Geneviève, F.;
- Lecompte, T.
Publication type:
Article
Mapping of chromosome 20 for loss of heterozygosity in childhood ALL reveals a 1,000-kb deletion in one patient.
Published in:
1999
By:
- Couque, N;
- Chambon-Pautas, C;
- Cavé, H;
- Bardet, V;
- Duval, M;
- Vilmer, E;
- Grandchamp, B
Publication type:
journal article
Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.
Published in:
Leukemia (08876924), 2013, v. 27, n. 10, p. 1981, doi. 10.1038/leu.2013.178
By:
- Mathis, S;
- Chapuis, N;
- Debord, C;
- Rouquette, A;
- Radford-Weiss, I;
- Park, S;
- Dreyfus, F;
- Lacombe, C;
- Béné, M C;
- Kosmider, O;
- Fontenay, M;
- Bardet, V
Publication type:
Article
Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML.
Published in:
Leukemia (08876924), 2012, v. 26, n. 10, p. 2297, doi. 10.1038/leu.2012.152
By:
- Ettou, S;
- Audureau, E;
- Humbrecht, C;
- Benet, B;
- Jammes, H;
- Clozel, T;
- Bardet, V;
- Lacombe, C;
- Dreyfus, F;
- Mayeux, P;
- Solary, E;
- Fontenay, M
Publication type:
Article
Efficacy of the association of lenalidomide to erythropoiesis-stimulating agents in del (5q) MDS patients refractory to single-agent lenalidomide.
Published in:
2010
By:
- Park, S.;
- Vassilieff, D.;
- Bardet, V.;
- Viguié, F.;
- Dreyfus, F.
Publication type:
Letter
Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies.
Published in:
Leukemia (08876924), 2010, v. 24, n. 10, p. 1686, doi. 10.1038/leu.2010.170
By:
- Chapuis, N.;
- Tamburini, J.;
- Green, A. S.;
- Willems, L.;
- Bardet, V.;
- Park, S.;
- Lacombe, C.;
- Mayeux, P.;
- Bouscary, D.
Publication type:
Article
PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML.
Published in:
Leukemia (08876924), 2008, v. 22, n. 9, p. 1698, doi. 10.1038/leu.2008.144
By:
- Park, S.;
- Chapuis, N.;
- Bardet, V.;
- Tamburini, J.;
- Gallay, N.;
- Willems, L.;
- Knight, Z. A.;
- Shokat, K. M.;
- Azar, N.;
- Viguié, F.;
- Ifrah, N.;
- Dreyfus, F.;
- Mayeux, P.;
- Lacombe, C.;
- Bouscary, D.
Publication type:
Article
Nucleophosmin status may influence the therapeutic decision in de novo acute myeloid leukemia with normal karyotype.
Published in:
2006
By:
- Bardet, V.;
- Costa, L. D.;
- Elie, C.;
- Malinge, S.;
- Demur, C.;
- Tamburini, J.;
- Lefebvre, P. C.;
- Witz, F.;
- Lioure, B.;
- Jourdan, E.;
- Pigneux, A.;
- Ifrah, N.;
- Attal, M.;
- Dreyfus, F.;
- Mayeux, P.;
- Lacombe, C.;
- Bennaceur-Griscelli, A.;
- Bernard, O. A.;
- Bouscary, D.;
- Récher, C.
Publication type:
Letter
Constitutive phosphoinositide 3-kinase activation in acute myeloid leukemia is not due to p110δ mutations.
Published in:
2006
By:
- Cornillet-Lefebvre, P.;
- Cuccuini, W.;
- Bardet, V.;
- Tamburini, J.;
- Gillot, L.;
- Ifrah, N.;
- Nguyen, P.;
- Dreyfus, F.;
- Mayeux, P.;
- Lacombe, C.;
- Bouscary, D.
Publication type:
Letter

Found: 9